Semisynthetic glycosaminoglycan ethers (SAGEs) are short, sulfated hyaluronans which combine the natural properties of hyaluronan with chemical sulfation. In a murine model, SAGEs provide protection against radiation induced proctitis (RIP), a side effect of lower abdominal radiotherapy for cancer. The anti-inflammatory effects of SAGE have been studied in inflammatory diseases at mucosal barrier sites; however, few mechanisms have been uncovered necessitating high throughput methods. SAGEs were combined with silk-elastinlike polymers (SELPs) to enhance rectal accumulation in mice. After high radiation exposure to the lower abdominal area, mice were followed for 3 days or until they met humane endpoints, before evaluation of behavioral pain responses and histological assessment of rectal inflammation. RNA sequencing was conducted on tissues from the 3-day cohort to determine molecular mechanisms of SAGE–SELP. After 3 days, mice receiving the SAGE–SELP combination yielded significantly lowered pain responses and amelioration of radiation-induced rectal inflammation. Mice receiving the drug–polymer combination survived 60% longer than other irradiated mice, with a fraction exhibiting long term survival. Sequencing reveals varied regulation of toll like receptors, antioxidant activities, T-cell signaling, and pathways associated with pain. This investigation elucidates several molecular mechanisms of SAGEs and exhibits promising measures for prevention of RIP.
Background: Chronic bladder pain in interstitial cystitis often persists without overt inflammation, highlighting the need for physiologically relevant experimental models and effective non-opioid therapies. Objective: This study aims to evaluate the impact of persistent inflammation on bladder pain using an LL-37–induced murine model of interstitial cystitis/painful bladder syndrome (IC/PBS). We hypothesized that chronic pain could develop independently of ongoing inflammation and that a sulfated glycosaminoglycan ether (SAGE) compound could attenuate the pain and inflammation elicited by LL-37. Methods: Female C57BL/6 mouse bladders were instilled biweekly with 80 μM LL-37, a human antimicrobial peptide with immunomodulatory properties, for 1 h over four weeks. The analgesic efficacy of SAGE GM-0111, a sulfated hyaluronic acid derivative, was assessed by intravesical instillation immediately prior to LL-37 exposure. Pain responses were quantified using von Frey filaments (0.04–4.0 g). Inflammation and fibrosis were evaluated via myeloperoxidase and total collagen assays, gross examination, and histological analysis. Results: LL-37–treated animals exhibited significantly elevated pain responses (98.00 ± 0.42% positive response) compared to repeated saline controls (55.00 ± 3.80%; p < 0.001) and SAGE GM-0111–treated animals (54.17 ± 3.28%; p < 0.01). Despite pronounced hyperalgesia, no significant inflammation or fibrosis was detected by myeloperoxidase and collagen assays or histological evaluation. Conclusion: Repeated intravesical LL-37 administration induces a chronic pain phenotype that closely models human IC/PBS, wherein bladder pain occurs independently of overt inflammation. Furthermore, SAGE GM-0111 exerts significant analgesic effects in this model. This platform provides a valuable tool for elucidating mechanisms underlying bladder pain in IC/PBS, particularly in cases lacking evident inflammation or fibrosis.
We present a rare case of recurrent idiopathic ischemic priapism in a healthy 14-year-old male with no identifiable risk factors such as hematologic disorders, trauma, or medication use. The patient required surgical intervention after failing conservative measures, including aspiration and intracavernosal phenylephrine. A bilateral T-shunt ultimately achieved successful detumescence. Postoperative rehabilitation with tadalafil and a vacuum erection device preserved erectile function. This case highlights the importance of early recognition and a stepwise approach to pediatric priapism. It also raises the possibility of a novel association between chronic constipation and impaired venous outflow contributing to priapism in children.
About Me
Associate Professor of Surgery/Pediatric Urology, Boston Children's Hospital/Harvard Medical School
Associate Professor of Surgery/Pediatric Urology, Boston Children's Hospital/Harvard Medical School